Medtronic plc.Updated MedTronic - What is your Opinion? Shall we discuss it?
This time as an experiment, why don't we discuss the prospects before taking action-
HERE IS MY CONTRIBUTION - can we all collaborate ?
What Medtronic is doing right:
It looks like these guys make transplant patients nervouse, nervous to have their pace makers hacked. That has t increase liability does it not?
Proactive identification: Medtronic identified the cybersecurity vulnerability in their Paceart Optima system during routine monitoring.
Prompt reporting: The company reported the issue to the U.S. Cybersecurity & Infrastructure Security Agency (CISA).
Transparency: Medtronic issued a security bulletin and provided information about the vulnerability.
Rapid response: The company developed and released an update (v1.12) to address the vulnerability.
Customer communication: Medtronic notified healthcare organizations about the issue and provided instructions to eliminate the vulnerability.
Commitment to security: The company stated they take potential cybersecurity vulnerabilities very seriously.
Vulnerabilities:
Critical flaw in Paceart Optima system: The vulnerability (CVE-2023-31222) has a critical CVSS score of 9.8 out of 1035.
Remote code execution risk: If exploited, the vulnerability could allow unauthorized users to perform remote code execution or launch denial-of-service attacks.
Data compromise: Hackers could potentially delete, steal, or modify cardiac device data.
Network penetration: The vulnerability could be used as a gateway for further network penetration in healthcare organizations.
Legacy devices: The issue affects older versions of the software (v1.11 and earlier), highlighting the need for regular updates.
Optional feature risk: The vulnerability exists in an optional messaging feature, which if enabled, exposes the system to potential attacks.
Historical vulnerabilities: Medtronic has faced previous scrutiny for security issues in other devices, such as insulin pumps and defibrillators.
HERE IS MY CONTRIBUTION - can we all collaborate ?
What Medtronic is doing right:
It looks like these guys make transplant patients nervouse, nervous to have their pace makers hacked. That has t increase liability does it not?
Proactive identification: Medtronic identified the cybersecurity vulnerability in their Paceart Optima system during routine monitoring.
Prompt reporting: The company reported the issue to the U.S. Cybersecurity & Infrastructure Security Agency (CISA).
Transparency: Medtronic issued a security bulletin and provided information about the vulnerability.
Rapid response: The company developed and released an update (v1.12) to address the vulnerability.
Customer communication: Medtronic notified healthcare organizations about the issue and provided instructions to eliminate the vulnerability.
Commitment to security: The company stated they take potential cybersecurity vulnerabilities very seriously.
Vulnerabilities:
Critical flaw in Paceart Optima system: The vulnerability (CVE-2023-31222) has a critical CVSS score of 9.8 out of 1035.
Remote code execution risk: If exploited, the vulnerability could allow unauthorized users to perform remote code execution or launch denial-of-service attacks.
Data compromise: Hackers could potentially delete, steal, or modify cardiac device data.
Network penetration: The vulnerability could be used as a gateway for further network penetration in healthcare organizations.
Legacy devices: The issue affects older versions of the software (v1.11 and earlier), highlighting the need for regular updates.
Optional feature risk: The vulnerability exists in an optional messaging feature, which if enabled, exposes the system to potential attacks.
Historical vulnerabilities: Medtronic has faced previous scrutiny for security issues in other devices, such as insulin pumps and defibrillators.
Order cancelled
I hear they could fce a lot of litigation. from pace makers and radio frequency interference = just watching it for now 
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.